Real-World Estimates of Adrenal Insufficiency-Related Adverse Events in Children With Congenital Adrenal Hyperplasia.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 29 05 2020
accepted: 24 09 2020
pubmed: 1 10 2020
medline: 3 9 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

Although congenital adrenal hyperplasia (CAH) is known to be associated with adrenal crises (AC), its association with patient- or clinician-reported sick day episodes (SDE) is less clear. Data on children with classic 21-hydroxylase deficiency CAH from 34 centers in 18 countries, of which 7 were Low or Middle Income Countries (LMIC) and 11 were High Income (HIC), were collected from the International CAH Registry and analyzed to examine the clinical factors associated with SDE and AC. A total of 518 children-with a median of 11 children (range 1, 53) per center-had 5388 visits evaluated over a total of 2300 patient-years. The median number of AC and SDE per patient-year per center was 0 (0, 3) and 0.4 (0.0, 13.3), respectively. Of the 1544 SDE, an AC was reported in 62 (4%), with no fatalities. Infectious illness was the most frequent precipitating event, reported in 1105 (72%) and 29 (47%) of SDE and AC, respectively. On comparing cases from LMIC and HIC, the median SDE per patient-year was 0.75 (0, 13.3) vs 0.11 (0, 12.0) (P < 0.001), respectively, and the median AC per patient-year was 0 (0, 2.2) vs 0 (0, 3.0) (P = 0.43), respectively. The real-world data that are collected within the I-CAH Registry show wide variability in the reported occurrence of adrenal insufficiency-related adverse events. As these data become increasingly used as a clinical benchmark in CAH care, there is a need for further research to improve and standardize the definition of SDE.

Sections du résumé

BACKGROUND
Although congenital adrenal hyperplasia (CAH) is known to be associated with adrenal crises (AC), its association with patient- or clinician-reported sick day episodes (SDE) is less clear.
METHODS
Data on children with classic 21-hydroxylase deficiency CAH from 34 centers in 18 countries, of which 7 were Low or Middle Income Countries (LMIC) and 11 were High Income (HIC), were collected from the International CAH Registry and analyzed to examine the clinical factors associated with SDE and AC.
RESULTS
A total of 518 children-with a median of 11 children (range 1, 53) per center-had 5388 visits evaluated over a total of 2300 patient-years. The median number of AC and SDE per patient-year per center was 0 (0, 3) and 0.4 (0.0, 13.3), respectively. Of the 1544 SDE, an AC was reported in 62 (4%), with no fatalities. Infectious illness was the most frequent precipitating event, reported in 1105 (72%) and 29 (47%) of SDE and AC, respectively. On comparing cases from LMIC and HIC, the median SDE per patient-year was 0.75 (0, 13.3) vs 0.11 (0, 12.0) (P < 0.001), respectively, and the median AC per patient-year was 0 (0, 2.2) vs 0 (0, 3.0) (P = 0.43), respectively.
CONCLUSIONS
The real-world data that are collected within the I-CAH Registry show wide variability in the reported occurrence of adrenal insufficiency-related adverse events. As these data become increasingly used as a clinical benchmark in CAH care, there is a need for further research to improve and standardize the definition of SDE.

Identifiants

pubmed: 32995889
pii: 5913019
doi: 10.1210/clinem/dgaa694
pmc: PMC7990061
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e192-e203

Subventions

Organisme : Medical Research Council
ID : G1100236
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003403/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Int J Mol Sci. 2019 Sep 07;20(18):
pubmed: 31500256
Horm Res Paediatr. 2017;88(5):339-346
pubmed: 28898882
Orphanet J Rare Dis. 2017 Mar 20;12(1):56
pubmed: 28320446
J Clin Endocrinol Metab. 2020 Feb 1;105(2):
pubmed: 31532828
Eur J Endocrinol. 2016 Feb;174(2):177-86
pubmed: 26563979
Diagnosis (Berl). 2019 Nov 26;6(4):343-350
pubmed: 31256064
J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):847-51
pubmed: 25781528
J Clin Endocrinol Metab. 2016 Feb;101(2):364-89
pubmed: 26760044
Endocr J. 2003 Dec;50(6):745-52
pubmed: 14709847
Horm Res Paediatr. 2018;89(3):166-171
pubmed: 29455197
J Clin Endocrinol Metab. 2012 Dec;97(12):4429-38
pubmed: 22990093
Clin Endocrinol (Oxf). 2018 Jul;89(1):22-29
pubmed: 29617051
Eur J Endocrinol. 2010 Jan;162(1):115-20
pubmed: 19776201
Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):193-208
pubmed: 19500763
Eur J Endocrinol. 2012 Jul;167(1):35-42
pubmed: 22513882
Eur J Endocrinol. 2018 Apr;178(4):309-320
pubmed: 29371334
Clin Endocrinol (Oxf). 2018 Nov;89(5):577-585
pubmed: 30086199
Clin Endocrinol (Oxf). 2016 Jan;84(1):17-22
pubmed: 26208266
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e192-e203
pubmed: 32995889
N Engl J Med. 2019 Aug 29;381(9):852-861
pubmed: 31461595
J Pediatr Endocrinol Metab. 2019 Jun 26;32(6):615-622
pubmed: 31141483
Ther Adv Endocrinol Metab. 2019 Jun 13;10:2042018819848218
pubmed: 31223468
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2336-2345
pubmed: 29584889
Eur J Endocrinol. 2010 Mar;162(3):597-602
pubmed: 19955259
Pediatrics. 2007 Feb;119(2):e484-94
pubmed: 17242136
BMC Endocr Disord. 2018 Jun 8;18(1):37
pubmed: 29884168
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4043-4088
pubmed: 30272171
J Spec Pediatr Nurs. 2017 Oct;22(4):
pubmed: 28771930
Horm Res Paediatr. 2018;89(5):341-351
pubmed: 29874655
Clin Endocrinol (Oxf). 2015 Jan;82(1):2-11
pubmed: 25187037
Eur J Endocrinol. 2013 Oct 21;169(6):R165-75
pubmed: 24031090
Eur J Intern Med. 2019 Jun;64:24-28
pubmed: 30979617
Eur J Pediatr. 2019 May;178(5):731-738
pubmed: 30806790
Lancet Diabetes Endocrinol. 2013 Dec;1(4):341-52
pubmed: 24622419
Horm Res. 2002;58(4):196-205
pubmed: 12324719
Swiss Med Wkly. 2018 Jan 29;148:w14586
pubmed: 29376554
J Clin Endocrinol Metab. 2014 Dec;99(12):E2715-21
pubmed: 25279502
Clin Endocrinol (Oxf). 2013 Jan;78(1):23-8
pubmed: 23009615
Endocr Rev. 2000 Jun;21(3):245-91
pubmed: 10857554
N Engl J Med. 1987 Oct 22;317(17):1098
pubmed: 3657876
J Genet Couns. 2018 Dec;27(6):1447-1458
pubmed: 29982889
Int J Endocrinol. 2016;2016:5748264
pubmed: 26880914

Auteurs

Salma R Ali (SR)

Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK.
Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK.

Jillian Bryce (J)

Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK.

Houra Haghpanahan (H)

Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

James D Lewsey (JD)

Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Li En Tan (LE)

Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK.

Navoda Atapattu (N)

Lady Ridgeway Hospital, Colombo, Sri Lanka.

Niels H Birkebaek (NH)

Department of Paediatrics, Aarhus University Hospital, Aarhus, Denmark.

Oliver Blankenstein (O)

Centre for Chronic Sick Children, Institute for Experimental Paediatric Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Uta Neumann (U)

Centre for Chronic Sick Children, Institute for Experimental Paediatric Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Antonio Balsamo (A)

Department of Medical and Surgical Sciences, Pediatric Unit, Center for Rare Endocrine Conditions (Endo-ERN), S.Orsola-Malpighi University Hospital, Bologna, Italy.

Rita Ortolano (R)

Department of Medical and Surgical Sciences, Pediatric Unit, Center for Rare Endocrine Conditions (Endo-ERN), S.Orsola-Malpighi University Hospital, Bologna, Italy.

Walter Bonfig (W)

Department of Paediatrics, Technical University München, Munich, Germany.
Department of Paediatrics, Klinikum Wels-Grieskirchen, Wels, Austria.

Hedi L Claahsen-van der Grinten (HL)

Department of Paediatric Endocrinology, Amalia Childrens Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.

Martine Cools (M)

University Hospital Ghent, Ghent University, Ghent, Belgium.

Eduardo Correa Costa (EC)

Pediatric Surgery Service, Hospital de Clínicas de Porto Alegre, UFRGS, Porto Alegre, Brazil.

Feyza Darendeliler (F)

Istanbul Faculty of Medicine, Department of Paediatrics, Paediatric Endocrinology Unit, Istanbul University, Istanbul, Turkey.

Sukran Poyrazoglu (S)

Istanbul Faculty of Medicine, Department of Paediatrics, Paediatric Endocrinology Unit, Istanbul University, Istanbul, Turkey.

Heba Elsedfy (H)

Department of Pediatrics, Ain Shams University, Cairo, Egypt.

Martijn J J Finken (MJJ)

Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Endocrinology, Amsterdam, The Netherlands.

Christa E Fluck (CE)

Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics and Department of BioMedical Research, Bern University Hospital Inselspital, University of Bern, Bern, Switzerland.

Evelien Gevers (E)

Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.

Márta Korbonits (M)

Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.

Guilherme Guaragna-Filho (G)

Department of Pediatrics, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

Tulay Guran (T)

Marmara University, Department of Pediatric Endocrinology and Diabetes, Pendik, Istanbul, Turkey.

Ayla Guven (A)

Health Science University, Medical Faculty, Zeynep Kamil Women and Children Hospital, Pediatric Endocrinology Clinic, Istanbul, Turkey.

Sabine E Hannema (SE)

Department of Paediatric Endocrinology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Paediatrics, Leiden University Medical Center, Leiden, The Netherlands.

Claire Higham (C)

Department of Endocrinology, Christie Hospital NHS Foundation Trust, Manchester, University Of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Ieuan A Hughes (IA)

Department of Paediatrics, University of Cambridge, Cambridge, UK.

Rieko Tadokoro-Cuccaro (R)

Department of Paediatrics, University of Cambridge, Cambridge, UK.

Ajay Thankamony (A)

Department of Paediatrics, University of Cambridge, Cambridge, UK.

Violeta Iotova (V)

Department of Paediatrics, Medical University-Varna, UMHAT "Sv. Marina," Varna, Bulgaria.

Nils P Krone (NP)

Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

Ruth Krone (R)

Birmingham Women's & Children's Hospital, Department for Endocrinology & Diabetes, Birmingham, UK.

Corina Lichiardopol (C)

Department of Endocrinology, University of Medicine and Pharmacy Craiova, University Emergency Hospital, Craiova, Romania.

Andrea Luczay (A)

Department of Paediatrics, Semmelweis University, Budapest, Hungary.

Berenice B Mendonca (BB)

Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Disciplina de Endocrinologia, Hospital Das Clinicas, Faculdade De Medicina, Universidade de Sao Paulo, São Paulo, Brazil.

Tania A S S Bachega (TASS)

Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Disciplina de Endocrinologia, Hospital Das Clinicas, Faculdade De Medicina, Universidade de Sao Paulo, São Paulo, Brazil.

Mirela C Miranda (MC)

Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Disciplina de Endocrinologia, Hospital Das Clinicas, Faculdade De Medicina, Universidade de Sao Paulo, São Paulo, Brazil.

Tatjana Milenkovic (T)

Department of Endocrinology, Mother and Child Health Care Institute of Serbia "Dr Vukan Čupić," Belgrade, Serbia.

Klaus Mohnike (K)

University of Magdeburg, Magdeburg, Germany.

Anna Nordenstrom (A)

Karolinska University Hospital, Stockholm, Sweden.

Silvia Einaudi (S)

Pediatric Endocrinology Regina Margherita Children's Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy.

Hetty van der Kamp (H)

Wilhelmina Kinderziekenhuis, Division of Pediatric Endocrinology, Utrecht, Netherlands.

Ana Vieites (A)

Centro de Investigaciones Endocrinológicas, División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.

Liat de Vries (L)

The Jesse and Sara Lea Shafer Institute of Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petah Tikvah, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Richard J M Ross (RJM)

Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

S Faisal Ahmed (SF)

Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK.
Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH